| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 31.88 | 1.9% | 16.4% |
| Total Income | 31.88 | 1.9% | 16.4% |
| Expenditure | 30.02 | 0.8% | 23.1% |
| PBT | 1.22 | 25.8% | 58.5% |
| Net Profit | 1.12 | 21.7% | 61.4% |
| OPM | 5.84% | 2.64pp | 5.10pp |
| NPM | 3.52% | 0.57pp | 7.08pp |
| EPS | 0.00 | 100.0% | 100.0% |
CareCloud Reports Q2 2026 Results: Revenue Grows 16% to $31.9 Million
06 Aug 2026 · 6 Aug, 4:55 pm
Summary
CareCloud announced its second quarter 2026 results, with revenue growing 16% year-over-year to $31.9 million. The company maintained profitability for the ninth consecutive quarter, reporting GAAP net income of $1.1 million, though GAAP EPS decreased to $0.00 from $0.04 in Q2 2025. Adjusted EBITDA was $5.9 million. Management highlighted the strategic acquisition of Empower Healthcare & Compliance Partners as a key accomplishment, expanding into a new market segment. The company reaffirmed its full-year 2026 revenue guidance of $128 million to $132 million.
Key Highlights
- 1
CareCloud reported revenue of $31.9 million for the second quarter of 2026, an increase of 16% compared to $27.4 million in Q2 2025.
- 2
The company achieved its ninth consecutive quarter of positive GAAP net income, reporting $1.1 million for Q2 2026.
- 3
GAAP EPS for Q2 2026 was $0.00 per share, compared to $0.04 per share in the prior year's second quarter.
- 4
Adjusted EBITDA for Q2 2026 was $5.9 million, a slight decrease from $6.5 million in Q2 2025.
- 5
Year-to-date 2026 revenue reached $63.2 million, up from $55.0 million in the same period last year.
- 6
CareCloud expanded its product portfolio by acquiring Empower Healthcare & Compliance Partners, entering the compliance and audit-defense market.
- 7
The company reaffirmed its full-year 2026 guidance, expecting revenue between $128 million and $132 million.
Management Comments
Stephen Snyder
This quarter we grew revenue 16%, delivered our ninth consecutive quarter of positive GAAP net income, and entered the compliance and audit-defense market through our acquisition of Empower Healthcare. We’re investing deliberately in what we believe defines our next phase of growth — our AI solutions, our expanding capabilities, and the cross-sell opportunity across our more than 40,000 providers.
A. Hadi Chaudhry
Our AI and acquisition strategies have become a single, unified growth engine. Every platform we bring into CareCloud becomes smarter, faster, and more valuable when we layer in our AI capabilities. We are still in the early innings of unlocking the cross-sell potential across our expanded client base, and we are increasingly seeing customers adopt our AI-enabled offerings.
Norman Roth
As expected, profitability this quarter reflects deliberate investments we are making today — increased R&D spending on our AI-enabled capabilities and increased interest expense from simplifying our capital structure through the Series B redemption — that we believe will deliver returns over time. We expect these investments to enhance scalability, improve operational efficiency, and support long-term margin expansion.
Informational and educational content only. Not investment advice.